Skip to main content
. 2009 Feb 11;29(6):1796–1804. doi: 10.1523/JNEUROSCI.5729-08.2009

Figure 3.

Figure 3.

PKC activation with 0.1 μm PMA showed a modest improvement in CAP recovery after OGD, which was not additive with the α2AR agonist medetomodine, suggesting a common pathway. Numbers within the bars represent the number of nerves used for each treatment. Error bars indicate SD. *p < 0.002 versus control.